Source comparison
Melanotan-1 Myths: Cost and Safety Comparison
'Research-grade' guarantees purity $120–$180 per contaminated vial; 60% chance of underdosing or endotoxin exposure Systemic inflammatory response, unpredictable dosing, injection site infection Only third-party HPLC-MS verified batches confirm stated concentr
This comparison does not assign a generated winner or score.
- 'Research-grade' guarantees purity
- $120–$180 per contaminated vial; 60% chance of underdosing or endotoxin exposure
- Systemic inflammatory response, unpredictable dosing, injection site infection
- Only third-party HPLC-MS verified batches confirm stated concentration and purity
- Contamination is the norm, not the exception. Independent assays are non-negotiable
- Increased pigmentation replaces sunscreen
- Indirect: $800–$3,500 in dermatology procedures for UV-induced lesions over 3 years
- 1.7× higher actinic keratosis incidence; 2.1× higher atypical nevus development
- Melanin provides SPF 2–4 equivalent. Does not prevent DNA damage or reduce melanoma risk
- Pigmentation delays visible burn but allows silent photoaging and mutagenesis
- Higher doses produce faster tanning
- 2–3× peptide cost per cycle; $300–$600 wasted annually on excess dosing
- 65% nausea incidence at 2mg vs 40% at 1mg; MC4R cross-reactivity side effects
- MC1R saturation occurs at 1mg daily; melanogenesis is tyrosinase rate-limited, not dose-limited
- Overdosing increases adverse events without accelerating pigmentation
- Oral melanotan-1 formulations work
- $80–$150 per ineffective product
- Zero melanogenic effect; potential GI irritation from filler compounds
- Peptides undergo proteolytic degradation in the stomach; subcutaneous route required for bioavailability
- Oral forms are biologically inert. A complete financial loss
- Melanotan-1 is 'safer' than melanotan-2
- Minimal if peptide is verified pure; user assumes both are equivalent risk
- Both trigger MC1R; MT-2 has additional MC4R agonism (appetite, libido effects)
- MT-1 has narrower receptor selectivity but contamination risk is identical for unregulated sources
- Safety depends entirely on source verification, not peptide type